Total Payments
$1,908
2024 Payments
$1,908
Companies
22
Transactions
115
Medicare Patients
497
Medicare Billing
$29,506
Payment Breakdown by Category
Food & Beverage$1,908 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,908 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $402.68 | 28 | $0 (2024) |
| Lilly USA, LLC | $387.01 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $229.50 | 12 | $0 (2024) |
| Novo Nordisk Inc | $147.01 | 11 | $0 (2024) |
| Lundbeck LLC | $88.47 | 5 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $85.65 | 5 | $0 (2024) |
| Axsome Therapeutics, Inc. | $68.28 | 2 | $0 (2024) |
| Amgen Inc. | $63.61 | 3 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $60.19 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $54.04 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,908 | 115 | ABBVIE INC. ($402.68) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $22.53 | General |
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/12/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Opioid Use Disorder | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 102 | 105 | $15,447 | $4,487 |
| 2022 | 2 | 279 | 306 | $49,855 | $17,464 |
| 2021 | 3 | 116 | 126 | $18,259 | $7,555 |
Total Patients
497
Total Services
537
Medicare Billing
$29,506
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 59 | $9,985 | $2,774 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 46 | $5,462 | $1,714 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 275 | $46,494 | $16,298 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 31 | $3,361 | $1,166 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 88 | $13,792 | $5,850 | 42.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 27 | $3,950 | $1,234 | 31.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 11 | 11 | $517.00 | $471.35 | 91.2% |
About Kayla Tackett, NP-C
Kayla Tackett, NP-C is a Adult Health healthcare provider based in Wheelersburg, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2021. The National Provider Identifier (NPI) number assigned to this provider is 1013502798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kayla Tackett, NP-C has received a total of $1,908 in payments from pharmaceutical and medical device companies, with $1,908 received in 2024. These payments were reported across 115 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,908).
As a Medicare-enrolled provider, Tackett has provided services to 497 Medicare beneficiaries, totaling 537 services with total Medicare billing of $29,506. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Other Specialties Nurse Practitioner
- Location Wheelersburg, OH
- Active Since 03/04/2021
- Last Updated 01/27/2024
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1013502798
Products in Payments
- VRAYLAR (Drug) $252.53
- MOUNJARO (Drug) $211.38
- BREZTRI (Drug) $171.06
- JARDIANCE (Drug) $128.59
- UBRELVY (Drug) $117.77
- REXULTI (Drug) $108.08
- Ozempic (Drug) $89.02
- EMGALITY (Drug) $68.80
- Auvelity (Drug) $68.28
- Austedo XR (Drug) $65.94
- Otezla (Drug) $63.61
- ACCRUFER (Drug) $60.19
- Kerendia (Drug) $42.80
- YUPELRI (Drug) $35.75
- AIRSUPRA (Drug) $35.44
- ABILIFY ASIMTUFII (Drug) $34.43
- XIFAXAN (Drug) $30.68
- GVOKE HYPOPEN (Drug) $24.48
- FARXIGA (Drug) $23.00
- TRULANCE (Drug) $22.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.